High-response intrauterine insemination cycles converted to low-cost in vitro fertilization.

Background: There is a trend to cancel intrauterine insemination (IUI) in women with a high response. The aim of this study was to evaluate the efficacy of low-cost in vitro fertilization (IVF) in high-response IUI cycles in comparison with conventional IVF.

Methods And Materials: A total of 46 women were included in the study.

Denudation and sperm injection interval timing: impact on outcome of intracytoplasmic sperm injection.

Background: Given the importance of timing of denudation and oocyte injection during assisted reproductive technology cycles, a study was undertaken of the impact of timing on the outcome of intracytoplasmic sperm injection in a cohort of patients from a private in vitro fertilization center.

Methods: The study included patients who underwent fresh intracytoplasmic sperm injection-embryo transfer by a single embryologist and gynecologist over a two-year period (January 2008 to March 2010). The primary outcome measure was the number of mature oocytes, and clinical pregnancy was the secondary outcome measure.

Hysteroscopic endometrial ablation is an effective alternative to hysterectomy in women with menorrhagia and large uteri.

Study Objectives: To examine the feasibility, safety, and outcome of hysteroscopic endometrial ablation, and to determine the volume of fluid absorbed during resection versus rollerball coagulation in women with menorrhagia and large uteri.

Design: Retrospective review (Canadian Task Force classification II-2).

Setting: University-affiliated teaching hospital.

Endometrial thermal balloon ablation with the ThermaChoice system: effect of intrauterine pressure and duration of treatment.

Study Objective: To determine the safety and efficacy of thermal balloon therapy under variable intrauterine pressures and durations of treatment.

Design: Retrospective cohort study. (Canadian Task Force classification II-1).

Comparison of pharmacokinetics of a conjugated equine estrogen preparation (premarin) and a synthetic mixture of estrogens (C.E.S.) in postmenopausal women.

Objective: To compare the pharmacokinetics and relative bioavailabilities of key estrogen components of Premarin (Wyeth-Ayerst, Canada) with those of a generic conjugated estrogen preparation, C.E.S.